Advisor Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Advisor Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$12K	Hold	100	–	–	﹤0.01%	4276
2019 Q3	$11K	Hold	100	–	–	﹤0.01%	4313
2019 Q2	$10K	Hold	100	–	–	﹤0.01%	4401
2019 Q1	$9K	Sell	100 -30	-23%	-$2.46K	﹤0.01%	4445
2018 Q4	$10K	Buy	130 +30	+30%	+$2.21K	﹤0.01%	4232
2018 Q3	$8K	Hold	100	–	–	﹤0.01%	4426
2018 Q2	$10K	Sell	100 -43	-30%	-$3.71K	﹤0.01%	4100
2018 Q1	$11K	Buy	143 +19	+15%	+$1.54K	﹤0.01%	4052
2017 Q4	$10K	Buy	124 +8	+7%	+$665	﹤0.01%	4125
2017 Q3	$10K	Sell	116 -255	-69%	-$24.5K	﹤0.01%	4013
2017 Q2	$42K	Buy	371 +271	+271%	+$30.3K	﹤0.01%	2967
2017 Q1	$10K	Sell	100 -19	-16%	-$2.03K	﹤0.01%	3811
2016 Q4	$13K	Hold	119	–	–	﹤0.01%	3512
2016 Q3	$14K	Sell	119 -212	-64%	-$25K	﹤0.01%	3385
2016 Q2	$34K	Buy	+331	New	+$38.4K	﹤0.01%	2700

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisor Group's CBPO Position: Q4 2019 in Review

Advisor Group held its China Biologic Products Holdings, Inc. (CBPO) position steady in Q4 2019 at 100 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #4276.

Advisor Group first reported a position in CBPO in Q2 2016 and has held it in 15 quarters since. The position peaked at $42K in Q2 2017. 87 funds tracked by Wall St. Rank hold CBPO as of Q4 2019.

Advisor Group held 100 shares of China Biologic Products Holdings, Inc. worth $12K as of Q4 2019.
Advisor Group left its China Biologic Products Holdings, Inc. share count unchanged in Q4 2019.
China Biologic Products Holdings, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4276 holding.
Advisor Group first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and has held it in 15 quarters since.
Advisor Group's China Biologic Products Holdings, Inc. position peaked at $42K in Q2 2017.
87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.